Concepedia

Author

Ann Hunter

Leicester Royal InfirmaryORCID

Also Known As

A Hunter, A P Hunter, A. Hunter, A. P. Hunter, ANN HUNTER, Alexander Hunter, Ann Hunter, Ann P Hunter, Ann P. Hunter, Ann Pendlebury Hunter

128

Publications

6.9K

Citations

38

H-Index

109

Concepts

All Affiliations

Leicester Royal InfirmaryUniversity College LondonHeartlands HospitalUniversity of BirminghamNottingham City Hospital
AH

About

Ann Hunter is an author at Leicester Royal Infirmary specializing in medicine, engineering, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

2.4K

2

Engineering

6

6

518

3

Health Sciences

5

5

753

4

Business

1

1

85

5

Education

1

1

10

Ann Hunter

×

53

Publications

6.5K

Citations

37

H-Index

YearCitations

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

Alan K. Burnett, Robert K. Hills, Donald Milligan,

Journal of Clinical Oncology

2010

644

Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton,

Journal of Clinical Investigation

2009

556

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills,

The Lancet Oncology

2015

533

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

Norbert Schmitz, Peter Dreger, Meinolf Suttorp,

Blood

1995

487

Sequencing of N-Linked Oligosaccharides Directly from Protein Gels: In-Gel Deglycosylation Followed by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Normal-Phase High-Performance Liquid Chromatography

Bernhard Küster, Susan F. Wheeler, Ann Hunter,

Analytical Biochemistry

1997

357

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

Ronjon Chakraverty, Karl S. Peggs, Rajesh Chopra,

Blood

2002

344

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

Karl S. Peggs, Ann Hunter, Rajesh Chopra,

The Lancet

2005

277

Allelic Variants of Human Cytochrome P450 2C9: Baculovirus-Mediated Expression, Purification, Structural Characterization, Substrate Stereoselectivity, and Prochiral Selectivity of the Wild-Type and I359L Mutant Forms

Robert L. Haining, Ann Hunter, Maurice E. Veronese,

Archives of Biochemistry and Biophysics

1996

253

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

Josè Antonio Pérez-Simón, Panagiotis Kottaridis, Rodrigo Martino,

Blood

2002

243

Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia

Sudhir Tauro, Charles Craddock, Karl S. Peggs,

Journal of Clinical Oncology

2005

225

Page 1